About PREVEP, INC.
PrevEp is a biotechnology company focused on developing first-in-class treatments for epilepsy, including preemptive seizure treatments and novel formulations for neonatal seizures. The company was founded by pioneers in epilepsy science with extensive experience in drug development and clinical trials.
Development of first-in-class therapies for epilepsyIntranasal seletracetam spray for rapid-onset, non-sedating, non-addictive preemptive seizure treatmentNetwork pharmacology approach using FDA-cleared combination therapies for epilepsy preventionNovel intravenous topiramate formulation for neonatal seizuresNovel intravenous atorvastatin formulation for hospitalized patientsEpilepsy prevention research targeting post-traumatic and post-stroke epilepsy
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to PREVEP, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.